Abstract
A DBU-catalyzed one-pot multicomponent reaction involving indane-1,3-dione, aldehydes, and 1,4-dithiane-2,5-diol for the synthesis of spirocyclic tetrahydrothiophene derivatives has been developed. A series of spirocyclic tetrahydrothiophene derivatives were obtained in generally good to excellent yields with high diastereoselectivity via this synthetic strategy. Importantly, this methodology has several advantages, such as mild reaction conditions, broad scope of substrates, easy operations and so on.
Keywords: Aldehydes, DBU, 1, 4-dithiane-2, 5-diol, indane-1, 3-dione, multi-component reaction, one-pot, organocatalysis, tetrahydrothiophene.
Current Organocatalysis
Title:DBU-Catalyzed One-Pot Multicomponent Reaction for the Synthesis of Spirocyclic Tetrahydrothiophene Derivatives
Volume: 3 Issue: 2
Author(s): Jindian Duan, Jing Cheng and Pengfei Li
Affiliation:
Keywords: Aldehydes, DBU, 1, 4-dithiane-2, 5-diol, indane-1, 3-dione, multi-component reaction, one-pot, organocatalysis, tetrahydrothiophene.
Abstract: A DBU-catalyzed one-pot multicomponent reaction involving indane-1,3-dione, aldehydes, and 1,4-dithiane-2,5-diol for the synthesis of spirocyclic tetrahydrothiophene derivatives has been developed. A series of spirocyclic tetrahydrothiophene derivatives were obtained in generally good to excellent yields with high diastereoselectivity via this synthetic strategy. Importantly, this methodology has several advantages, such as mild reaction conditions, broad scope of substrates, easy operations and so on.
Export Options
About this article
Cite this article as:
Duan Jindian, Cheng Jing and Li Pengfei, DBU-Catalyzed One-Pot Multicomponent Reaction for the Synthesis of Spirocyclic Tetrahydrothiophene Derivatives, Current Organocatalysis 2016; 3 (2) . https://dx.doi.org/10.2174/2213337202666150414201456
DOI https://dx.doi.org/10.2174/2213337202666150414201456 |
Print ISSN 2213-3372 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-3380 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Patent Selections
Recent Patents on Biotechnology Therapeutic Strategies in Parkinsons Disease
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Epigenetic Regulation of Epithelial to Mesenchymal Transition
Current Cancer Drug Targets Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Recent Patents on Anti-Cancer Drug Discovery Do Cytokines Associate Periodontitis with Metabolic Disorders? An Overview of Current Documents
Endocrine, Metabolic & Immune Disorders - Drug Targets Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 2: Calciferol and the Significance of Nutrient Supplements
Inflammation & Allergy - Drug Targets (Discontinued) Gut Microbiota and Gender in Autism Spectrum Disorders
Current Pediatric Reviews Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma
Medicinal Chemistry Adipose-derived Stem Cells: Potentials, Availability and Market Size in Regenerative Medicine
Current Stem Cell Research & Therapy Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease
Current Chemical Biology Semaphorins and their Receptors in Stem and Cancer Cells
Current Medicinal Chemistry Role of Phytochelators in Land Reclamation: Recent Progress and Perspectives
Current Environmental Engineering Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies
Current Neuropharmacology A QSAR Study on Some Series of Anti-Hepatitis C Virus (HCV) Agents
Letters in Drug Design & Discovery Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets
Current Gene Therapy Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
Current Medicinal Chemistry Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry The Heme-Heme Oxygenase System in Wound Healing; Implications for Scar Formation
Current Drug Targets